当前位置: X-MOL 学术Cell Biochem. Funct. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cystine‐glutamate antiporter xCT as a therapeutic target for cancer
Cell Biochemistry and Function ( IF 2.8 ) Pub Date : 2020-08-04 , DOI: 10.1002/cbf.3581
Lin Liu 1 , Rui Liu 2 , Yi Liu 1 , Guanghui Li 1 , Qing Chen 1 , Xiaodong Liu 1 , Shumei Ma 1
Affiliation  

Cystine/glutamic acid reverse transporter (System Xc), a member of the amino acid transporter family, consists of two subunits, light chain xCT and heavy chain 4F2hc. xCT is the cystine/glutamate antiporter solute carrier family 7 member 11 (SLC7A11), which promotes cystine uptake and glutathione biosynthetic, thus protecting against oxidative stress and ferroptosis. Studies have confirmed that xCT is highly expressed in a variety of tumour and is associated with tumour proliferation, invasion, metastasis, drug resistance and ferroptosis, and can be used as a potential target for tumour treatment. This review provides insights into the biological effects of xCT and contribute to the development of new xCT‐based strategies.

中文翻译:

胱氨酸谷氨酸逆转运蛋白xCT作为癌症的治疗靶标

胱氨酸/谷氨酸反向转运体(系统X Ç - ),氨基酸转运蛋白家族的一个成员,包括两个亚基,轻链XCT链和重链的4F2hc。xCT是胱氨酸/谷氨酸逆向转运蛋白溶质载体家族7成员11(SLC7A11),它促进胱氨酸的摄取和谷胱甘肽的生物合成,从而防止氧化应激和肥大症。研究已经证实,xCT在多种肿瘤中高表达,并且与肿瘤增殖,侵袭,转移,耐药性和肥大症有关,并且可以用作潜在的肿瘤治疗靶标。这篇综述提供了xCT生物学效应的见解,并为基于xCT的新策略的开发做出了贡献。
更新日期:2020-08-04
down
wechat
bug